Last updated on December 2018

Efficacy and Safety Study of BAY1841788 (ODM-201) in Men With High-risk Non-metastatic Castration-resistant Prostate Cancer (ARAMIS)


Brief description of study

The purpose of this study is to assess the safety and efficacy of BAY1841788 (ODM-201) in patients with non-metastatic castration-resistant prostate cancer.

Clinical Study Identifier: NCT02200614

Contact Investigators or Research Sites near you

Start Over

Praha 2, Czechia
1.28miles

Praha 8, Czechia
2.78miles

Praha 6, Czechia
4.86miles

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.